
CAS 939228-52-1
:CCI 007)
Description:
The chemical substance identified by the name "CCI 007" and CAS number "939228-52-1" is a synthetic compound that has garnered interest in various fields, particularly in medicinal chemistry and pharmacology. While specific details about its structure and properties may not be widely available, compounds with similar identifiers often exhibit unique biological activities or serve as intermediates in chemical synthesis. Typically, such substances are evaluated for their efficacy, safety, and potential applications in drug development. Characteristics of such compounds may include their solubility, stability under various conditions, and reactivity with other chemical species. Additionally, they may undergo rigorous testing to determine their pharmacokinetic and pharmacodynamic profiles. As with any chemical substance, understanding its characteristics is crucial for its application in research and industry, and ongoing studies may reveal more about its potential uses and effects. Always refer to reliable scientific literature or databases for the most accurate and detailed information regarding specific compounds.
Formula:C15H16N2O5S
Synonyms:- CCI 007)
- CCI-007
- Ethyl 2-(4-((2-amino-4-oxothiazol-5(4H)-ylidene)methyl)-2-methoxyphenoxy)acetate
- (CCI00
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
CCI-007
CAS:<p>CCI 007 is a selective inhibitor of MLL-r, CALM-AF10 and SET-NUP214 leukemia with IC50 of 3.5 uM against MLL-r leukemia cell line PER-485</p>Formula:C15H16N2O5SPurity:97.61%Color and Shape:SolidMolecular weight:336.36CCI-007
CAS:<p>CCI-007 is a potent human anticancer protein kinase inhibitor that has shown promising results in the treatment of various types of tumors. It is an analog of neopterin, a naturally occurring molecule found in human urine. CCI-007 works by inhibiting specific kinases that are involved in cancer cell growth and survival, leading to apoptosis (programmed cell death) of cancer cells. This inhibitor has been shown to be effective against Chinese hamster ovary cells and other cancer cell lines, making it a promising candidate for further development as an anticancer therapy. The unique mechanism of action of CCI-007 makes it a valuable addition to the growing arsenal of kinase inhibitors used in cancer treatment.</p>Formula:C15H16N2O5SPurity:Min. 95%Molecular weight:336.4 g/mol




